Masato Ishida

Masato Ishida

Auto-generated profile, based on publicly available information

Masato Ishida

Department of Respiratory and Immunology, Medical AstraZeneca KK Osaka Japan

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2021 in JMIR Medical Informatics
Verified
Journal Article
Open access
SMSHIGEO MURO
SHIGEO MURO
MIMasato Ishida
Masato Ishida
YHYoshiharu Horie
Yoshiharu Horie
WTWataru Takeuchi
Wataru Takeuchi
SNShunki Nakagawa
Shunki Nakagawa
Tetsuhisa KitamuraTetsuhisa Kitamura
Tetsuhisa Kitamura
Background: Airflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances, including tobacco smoke, is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist. Objective: This study aimed to predict the risk factors for COPD diagnosis using machine learning in an annual medical check-up database. Methods: In this retrospective observational cohort study (ARTDECO [Analysis of Risk Factors to Detect COPD]), annual medical check-up records for all Hitachi Ltd employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30 to 75 years without a prior diagnosis of COPD/asthma or a history of cancer were included. The database included clinical measurements (eg, pulmonary function tests) and questionnaire responses. To predict the risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning (XGBoost) method was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the prebronchodilator forced expiratory volume in 1 second (FEV1) to prebronchodilator forced vital capacity (FVC) was <0.7 during two consecutive examinations. Results: Of the 26,101 individuals screened, 1213 met the exclusion criteria, and thus, 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV1/FVC, smoking status, allergic symptoms, cough, pack years, hemoglobin A1c, serum albumin, mean corpuscular volume, percent predicted vital capacity, and percent predicted value of FEV1. The areas under the receiver operating characteristic curves of the XGBoost model and the logistic regression model were 0.956 and 0.943, respectively. Conclusions: Using a machine learning model in this longitudinal database, we identified a number of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan.

1 November 1993 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
TIT Itoh
T Itoh
MIM Ishida
M Ishida
YOY Onuki
Y Onuki
YTY Tsuda
Y Tsuda
HSH Shimada
H Shimada
HYH Yamada
H Yamada
The stereoselective disposition of carbenicillin epimers was studied in healthy human volunteers. There was a difference between the two epimers in the extent of plasma protein binding in vitro, with the unbound fraction of the R epimer being greater than that of the S epimer. Renal clearance (CLR) of each epimer was greater than the glomerular filtration rate, suggesting renal tubular secretion of both epimers. Although the CLR was greater for the R epimer, renal tubular secretion was greater for the S epimer. When probenecid was coadministered, the CLR of each epimer was significantly reduced and was approximately equal to the glomerular filtration rate. The difference in CLR between the two epimers was simply due to differences in plasma protein binding. The observations in the present study suggest that both carbenicillin epimers are secreted by an organic anion transport system in the renal proximal tubule in humans and that the two epimers may be distinguished in the secretion process, resulting in the differences in the secretion rates.

1 February 1997 in Quarterly Journal of Experimental Psychology
Verified
Journal Article
Closed access
MIMasato Ishida
Masato Ishida
MPMauricio R. Papini
Mauricio R. Papini
Search and browse 5 million articles across 13,000 publications from over 250 publishers by publication, subject, publisher, author or keyword.

1 January 1997
Verified
Book Chapter
Closed access
PDF file
HIHisao Ito
Hisao Ito
MIMasato Ishida
Masato Ishida
SOSatoshi Ohfuji
Satoshi Ohfuji
MOMitsuhiko Osaki
Mitsuhiko Osaki
HHHisae Hayashi
Hisae Hayashi
STShigeru Tatebe
Shigeru Tatebe

27 June 2025 in Respiratory Investigation
Verified
Journal Article
Open access
MNMakoto Nagata
Makoto Nagata
RYRyo Yamaguchi
Ryo Yamaguchi
MUMakiko Usami
Makiko Usami
MOMami Orimo
Mami Orimo
MIMasato Ishida
Masato Ishida

5 October 2020 in JMIR Preprints
Verified
Preprint
Open access
SMSHIGEO MURO
SHIGEO MURO
MIMasato Ishida
Masato Ishida
YHYoshiharu Horie
Yoshiharu Horie
WTWataru Takeuchi
Wataru Takeuchi
SNShunki Nakagawa
Shunki Nakagawa
Tetsuhisa KitamuraTetsuhisa Kitamura
Tetsuhisa Kitamura
BACKGROUND Airflow limitation is a critical physiological feature in chronic obstructive pulmonary disease (COPD), for which long-term exposure to noxious substances, including tobacco smoke, is an established risk. However, not all long-term smokers develop COPD, meaning that other risk factors exist. OBJECTIVE This study aimed to predict the risk factors for COPD diagnosis using machine learning in an annual medical check-up database. METHODS In this retrospective observational cohort study (ARTDECO [Analysis of Risk Factors to Detect COPD]), annual medical check-up records for all Hitachi Ltd employees in Japan collected from April 1998 to March 2019 were analyzed. Employees who provided informed consent via an opt-out model were screened and those aged 30 to 75 years without a prior diagnosis of COPD/asthma or a history of cancer were included. The database included clinical measurements (eg, pulmonary function tests) and questionnaire responses. To predict the risk factors for COPD diagnosis within a 3-year period, the Gradient Boosting Decision Tree machine learning (XGBoost) method was applied as a primary approach, with logistic regression as a secondary method. A diagnosis of COPD was made when the ratio of the prebronchodilator forced expiratory volume in 1 second (FEV1) to prebronchodilator forced vital capacity (FVC) was <0.7 during two consecutive examinations. RESULTS Of the 26,101 individuals screened, 1213 met the exclusion criteria, and thus, 24,815 individuals were included in the analysis. The top 10 predictors for COPD diagnosis were FEV1/FVC, smoking status, allergic symptoms, cough, pack years, hemoglobin A1c, serum albumin, mean corpuscular volume, percent predicted vital capacity, and percent predicted value of FEV1. The areas under the receiver operating characteristic curves of the XGBoost model and the logistic regression model were 0.956 and 0.943, respectively. CONCLUSIONS Using a machine learning model in this longitudinal database, we identified a number of parameters as risk factors other than smoking exposure or lung function to support general practitioners and occupational health physicians to predict the development of COPD. Further research to confirm our results is warranted, as our analysis involved a database used only in Japan.